CCND1 and colorectal cancer: As expected, cyclin D1 protein expression was decreased in a dose-dependent manner by 6-gingerol treatment in our study (Fig. 4), and these results were consistent with the reports by Seong-Ho Lee et al. about human colorectal cancer cells [24].